Prof. Dr. med. Günter K. Stalla, Munich
Current positions
Professor Stalla is
director of
MEDICOVER Neuroendocrinology Prof. Stalla and colleagues
with clinical study center, Munich, Germany. He has guest status at the Max Planck Institute of Psychiatry, Munich, and is research associate at the Medical Clinic and Outpatient Clinic IV, Munich. From 2020 to 2023 Professor Stalla was President of the German Society of Endocrinology
(Deutsche Gesellschaft für Endokrinologie e. V., DGE). Since April 2025 he is Honorary Member of the DGE.
Please download Professor Stalla's CV:
Medicover Neuroendocrinology Prof. Stalla and colleagues
At the MEDICOVER Neuroendocrinology in Munich
Professor Stalla works as an internal medicine doctor, endocrinologist and andrologist. His clinical focus areas are endocrinology, neuroendocrinology, diabetology and andrology.
Some of the focuses of treatment of Professor Stalla are:
- Obesity
- Pituitary diseases
- Hormone deficiency after traumatic brain injury
- Thyroid diseases, eg. Hashimoto's disease
- Diabetes mellitus type 2
- Osteoporosis
- Hormonally caused increased blood pressure
- Hormonal problems in pituitary disease
- Adrenal disease
- Syndrome of polycystic ovaries
- Sexual hormone disorders in men and women
- Disorders of sexual development and transsexualism
Prof. Dr. med. Günter Stalla has been listed as recommended physician by FOCUS Health
and as excellent physician by the
stern journal:
- for endocrinology and fat metabolism (Focus Top Physician since 2016)
- for endocrinology
(Stern Excellent Doctor 2024)
- for andrology
(Focus Top Physician since 2016; Stern Excellent Doctor 2024)
- for sexual disorders in patients with diabetes mellitus (Focus Top Physician since 2019
Professor Stalla's scientific profile
The main research interests of Professor Stalla are related to the pathomechanisms of hypo- and hyperpituitarisms. In vitro, ex vivo and animal studies are performed to elucidate the pathogenesis and pathophysiology of traumatic brain injury-induced pituitary insufficiency as well as the underlying mechanisms of pituitary tumorigenesis and pituitary adenoma associated excessive hormone secretion. Insights into the pathomechanisms at cellular and molecular level will provide a basis for the development of novel treatment concepts for these disorders.
You will find Professor Stalla's and colleagues practice
at:
Orleansplatz 381667 München
Tel: 089 - 904 200 560
Fax: 089 - 904 200 561
E-mail: neuroendo@medicover.de